Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Immunoglobulin After Relapse in Vasculitis
This study has been terminated.
Study NCT00307658   Information provided by Assistance Publique - Hôpitaux de Paris
First Received: March 27, 2006   Last Updated: May 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post Treatment.
Additional conditions recognized in this trial
Recurrence
Vasculitis
More general conditions related to this trial
Cardiovascular Diseases
Disease Attributes
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulin G
Immunoglobulins
Immunoglobulins, Intravenous
Immunosuppressive Agents
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services